April 20, 2026
/
Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing
broad spectrum antivirals using non-toxic carbohydrate-based drugs. They are pioneers
in glycovirology and stand alone in developing galectin inhibitor-based antiviral